...
首页> 外文期刊>Cytokine >High interleukin-12 production from stimulated peripheral blood mononuclear cells of type 2 diabetes patients.
【24h】

High interleukin-12 production from stimulated peripheral blood mononuclear cells of type 2 diabetes patients.

机译:2型糖尿病患者受刺激的外周血单核细胞产生高白介素12。

获取原文
获取原文并翻译 | 示例
           

摘要

Sugar control is important in patients with sepsis. Interleukin (IL)-12 induces the polarization of CD4(+) T cells to the T helper 1 (Th1) phenotype. Regulatory T (T(reg)) cells are important in immunity and disease. The aim of this work is to determine whether hyperglycemia or insulin alters IL-12 response in peripheral mononuclear cells (PBMCs). METHODS: The PBMCs from 15 type 2 diabetes mellitus (DM) patients and 13 healthy controls were used for cell analysis and culture with or without treatment by glucose and insulin or stimulation by lipopolysaccharide (LPS) for 1, 2, and 3 days. RESULTS: The IL-12 level in the supernatant of LPS-stimulated PBMCs in the DM patients was significantly higher than that of healthy controls from day 1 to day 3. Kinetic IL-12 responses of LPS-stimulated PBMCs in the DM patients from day 1 to day 3 were significantly higher than that in healthy controls. The LPS-stimulated PBMCs under glucose treatment produced more IL-12 in DM patients but this did not happen in healthy controls. In DM patients, insulin could suppress IL-12 production from stimulated PBMCs but not with additional glucose treatment. CONCLUSION: The PBMCs of LPS-treated DM patients produced more IL-12 than that of LPS-treated healthy controls did. Hyperglycemia influenced IL-12 response from PBMCs in DM patients to some degree during infection.
机译:糖控制对败血症患者很重要。白介素(IL)-12诱导CD4(+)T细胞向T辅助1(Th1)表型极化。调节性T(T(reg))细胞在免疫力和疾病中很重要。这项工作的目的是确定高血糖症或胰岛素是否改变外周单核细胞(PBMC)中的IL-12反应。方法:将15例2型糖尿病(DM)患者和13例健康对照者的PBMC用于细胞分析和培养,无论有无葡萄糖和胰岛素治疗或脂多糖(LPS)刺激1、2和3天。结果:从第1天到第3天,DM患者中LPS刺激的PBMC上清液中的IL-12水平显着高于健康对照组。从第3天开始,DM患者中LPS刺激的PBMC的动力学IL-12反应。第1至第3天明显高于健康对照组。在葡萄糖治疗下,LPS刺激的PBMC在DM患者中产生更多的IL-12,但在健康对照组中则没有。在DM患者中,胰岛素可以抑制刺激的PBMC产生IL-12,但不能通过额外的葡萄糖治疗来抑制。结论:LPS治疗的DM患者的PBMC产生的IL-12比LPS治疗的健康对照多。高血糖症在感染过程中一定程度上影响了DM患者PBMC的IL-12反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号